Catalyst Wire Dossier Catalyst Wire Dossier

Tecnemab K1

anti-melanoma mab fragments · Amersham Sorin.S.r.l.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tecnemab K1, covering 2009-12-31 to 2009-12-31. Get the full timeline:

Most recent: EMA Withdrawn: Tecnemab K1 (anti-melanoma mab fragments) — Amersham Sorin.S.r.l.

See pricing